Medical Center of Infertility
Banī Suwayf, 62521, Egypt
NCT Number: NCT03674385
This study evaluate the addition of Vit E to clomiphene citrate in the treatment of poly cystic ovary.Half the patients will receive both Vit E and clomiphene citrate the other half will receive clomiphene citrate only.
Looking for future studies?
Notify Me18 year–39 year
Female
Interventional
Phase 2
Banī Suwayf, 62521, Egypt
Clomiphene and vit E each used in treatment of pco but they do so by different mechanisms.
Clomifene is in the selective estrogen receptor modulator (SERM) family of medication. It works by causing the release of gonadotropin-releasing hormone by the hypothalamus, and subsequently gonadotropin from the anterior pituitary.
Vit E is used in treatment of pco due its anti-oxidant effect.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Vitamin E is sold as a dietary supplement, either by itself or incorporated into a multivitamin product. it also has anti-oxidant effect
Other names: toco 1000
Metformin is in the biguanide class. It works by decreasing glucose production by the liver and increasing the insulin sensitivity of body tissues. It is also used in the treatment of polycystic ovary syndrome (PCOS)
Other names: cidophage
is a medication used to treat infertility in women who do not ovulate
Other names: clomid
Time frame: 3 months
Follicles measure more than 18 mm will be considered mature follicles.
Ain Shams University
Other
Evaluation of the Clinical Outcome of Vitamin E as Adjuvant Therapy in Patients With Clomiphene Citrate Resistant Polycystic Ovary Syndrome
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02775734
Adnexal Diseases, Clomiphene Citrate Resistant Polycystic Ovary Syndrome
Cairo, Egypt
View Trial DetailsNCT06800170
Adnexal Diseases, Amenorrhea
Tbilisi, Georgia
View Trial DetailsNCT07723443
Adnexal Diseases, Cysts
Baghdad, Al-Rusafa, Iraq
View Trial DetailsNCT07711782
Adnexal Diseases, Cysts
Lahore, Pakistan
View Trial Details